Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
76 studies found for:    hypercoagulation OR thrombophilia OR blood clotting | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
hypercoagulation OR thrombophilia OR blood clotting | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Condition: Coronary Artery Bypass
Interventions: Drug: Prasugrel;   Drug: Placebo
2 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
Intervention:
3 Recruiting The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
Condition: Glanzmann Thrombasthenia
Intervention:
4 Recruiting Understanding the Role of Genes and Biomarkers in the Blood Clotting Process in Children With Acute Lung Injury
Condition: Respiratory Distress Syndrome, Adult
Intervention:
5 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
6 Recruiting Fatty Acid Regulation of Platelet Function in Diabetes
Conditions: Thrombosis;   Type 2 Diabetes Mellitus
Intervention: Other: omega-3 and -6 fatty acids and their 12-LOX oxylipins
7 Recruiting Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Conditions: Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions: Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
8 Recruiting Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
Condition: Acute Deep Vein Thrombosis
Interventions: Other: Exercise;   Other: Control
9 Recruiting Personalized Medicine Decision-Making in a Virtual Clinical Setting
Conditions: Deep Vein Thrombosis;   Blood Clots
Intervention:
10 Recruiting Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus
Conditions: Thrombosis;   Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Primrose oil;   Dietary Supplement: Fish Oil
11 Recruiting Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
Conditions: Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolus
Interventions: Drug: Twice daily enoxaparin prophylaxis;   Drug: Real time dose adjustment
12 Recruiting Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
Conditions: Thromboembolism of Vein VTE in Colorectal Cancer;   Thromboembolism of Vein in Pancreatic Cancer;   Thromboembolism of Vein in Non-small Cell Lung Cancer
Intervention: Drug: Isoquercetin
13 Recruiting Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.
Condition: Colon Polyps
Intervention: Procedure: Clip closure
14 Not yet recruiting Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Conditions: Deep Vein Thrombosis;   Post-Thrombotic Syndrome;   Venous Thrombosis
Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA);   Drug: Standard Anticoagulation Therapy
15 Recruiting Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Condition: HIV Infection
Interventions: Drug: Aspirin 81 mg daily;   Drug: Atorvastatin 40 mg daily
16 Recruiting Chronology of Occult and Gross Coagulopathy in Burn Patients
Condition: Thermal Burns
Intervention:
17 Recruiting Platelet Activity in Vascular Surgery and Cardiovascular Events
Conditions: Cardiovascular Disease;   Peripheral Artery Disease;   Critical Limb Ischemia
Intervention:
18 Recruiting Targeting Platelets in Chronic HIV Infection
Condition: HIV-1 Infection
Interventions: Drug: Clopidogrel;   Drug: Aspirin;   Drug: Placebo
19 Recruiting Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Aspirin
20 Recruiting Control of Major Bleeding After Trauma Study
Conditions: Trauma;   Hemorrhagic Shock
Interventions: Biological: Type AB plasma;   Drug: Crystalloid fluid (standard of care for resuscitation)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.